Inflammatory breast cancer in Tunisia: Epidemiological and clinical trends

Cancer

Volumn 116, Issue SUPPL. 11, 2010, Pages 2730-2735

  Boussen, Hamouda ^a   Bouzaiene, Hatem ^a   Hassouna, Jamel Ben ^a   Dhiab, Tarek ^a   Khomsi, Fathi ^a   Benna, Farouk ^a   Gamoudi, Amor ^a   Mourali, Nejib ^a   Hechiche, Monia ^a   Rahal, Khaled ^a   Levine, Paul H ^b  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Breast surface; Epidemiology; Frequency; Inflammatory breast cancer; Pouss e volutive; T4d

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER STAGING; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLAMMATORY BREAST CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; SOCIOECONOMICS; SYSTEMATIC REVIEW; TUNISIA; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER SURVIVAL; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; MAJOR CLINICAL STUDY; MASTECTOMY; PREMENOPAUSE; TREATMENT OUTCOME;

BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; TUNISIA;

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

EID: 77952689458     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25175     Document Type: Conference Paper

References (32)

1. Tabbane F, Muenz L, Jaziri M, Cammoun M, Belhassen S, Mourali N. Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia. Cancer. 1977;40:376-382. (Pubitemid 8157813)
2. Mourali N, Muenz L, Tabbane F, et al. Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer. 1980;46:2741-2746. (Pubitemid 11210246)
3. Mourali N, Tabbane F, Muenz LR, et al. Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic, rapidly progressing breast cancer. Cancer Invest. 1993;11:363-370. (Pubitemid 23225910)
4. Levine PH, Mourali N, Tabbane F, et al. Studies on the role of cellular immunity and genetics in the etiology of rapidly progressing breast cancer in Tunisia. Int J Cancer. 1981;27:611-615. (Pubitemid 11101746)
5. Costa J, Webber BL, Levine PH, et al. Histopathological features of rapidly progressing breast carcinoma in Tunisia: a study of 94 cases. Int J Cancer. 1982;30:35-37. (Pubitemid 12044232)
6. Levine PH, Mesa-Tejada R, Keydar I, Tabbane F, Spiegelman S, Mourali N. Increased incidence of mouse mammary tumor virus-related antigen in Tunisian patients with breast cancer. Int J Cancer. 1984;33:305-308. (Pubitemid 14159024)
7. Levine PH, Tabbane F, Muenz LR, et al. Hormone receptors in rapidly progressing breast cancer. Cancer. 1984;54: 3012-3016.
8. Tabbane F, Bahi J, Rahal K, et al. Inflammatory symptoms in breast cancer. Correlations with growth rate, clinicopathologic variables, and evolution. Cancer. 1989;64:2081-2089.
9. McCarthy NJ, Yang X, Linnoila IR, et al. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer. Clin Cancer Res. 2002;8:3857-3862.
10. Levine PH, Pogo BG, Klouj A, et al. Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer. 2004;101:721-726.
11. Le MG, Arriagada R, Contesso G, et al. Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients. Clin Breast Cancer. 2005;6:439-445.
12. Hortobagyi GN, Buzdar AU. Progress in inflammatory breast cancer: cause for cautious optimism. J Clin Oncol. 1986;4:1727-1729.
13. Rouesse J, Friedman S, Sarrazin D, et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol. 1986;4:1765-1771. (Pubitemid 17226665)
14. Jayesimi IA, Buzdar AU, Hortobagyi G. Inflammatory breast cancer: a review. J Clin Oncol. 1992;10:1014-1024.
15. Cancer Registry of the North of Tunisia. Data 1999-2003. Tunis, Tunisia: Ministry of Health; 2009.
16. Globocan. Cancer in Five Continents. Lyon, France: International Agency for Research in Cancer; 2002.
17. Maalej M, Frikha H, Ben Salem S, et al. Breast cancer in Tunisia: clinical and epidemiological study. Bull Cancer. 1999;86:302-306. (Pubitemid 29196091)
18. Maalej M, Hentati D, Messai T, et al. Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study. Bull Cancer. 2008;95:E5-E9.
19. Ben Ahmed S, Aloulou S, Bibi M, et al. Breast cancer prognosis in Tunisian women: analysis of a hospital series of 729 patients. Sante Publique. 2002;14:231-241.
20. Boussen H, Bouzaiene H, Ben Hassouna J, Gamoudi A, Benna F, Rahal K. Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features. Semin Oncol. 2008;35:17-24. (Pubitemid 351282397)
21. Labidi I, Mrad K, Mezlini A, et al. Inflammatory breast cancer in Tunisia in the era of multimodality therapy. Ann Oncol. 2008;19:473-480. (Pubitemid 351325667)
22. Ghazzai Y, Boussen H, Rahal K, et al. Poster E3 presented at: First Inflammatory Breast Cancer Conference; December 4-6, 2008; Houston, Tex.
23. Ben Abdallah M. Epidemiologie des cancers en Tunisie. Registre de l'institut Salah Azaiz 1969-1985. Tunis, Tunisia: Ministry of Health; 1997.
24. Ben Hamida A, Labidi I, Mrad K, et al. Markers of subtypes of inflammatory breast cancers studied by immunohistochemistry: prominent expression of P-cadherin. BMC Cancer. 2008;8:28.
25. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC cancer staging manual. CA Cancer J Clin. 2006;56:37-47.
26. Denoix P. Treatment of malignant tumors of the breast. Rec Res Cancer Res. 1970;31:6-10.
27. Levine PH, Steinhorn SC, Ries LG, Aron JL. Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) program. J Natl Cancer Inst. 1985;74:291-297.
28. Chang S, Parker SL, Pham T, et al. Inflammatory breast cancer incidence and survival: the Surveillance Epidemiology and End Results program of the National Cancer Institute, 1975-1992. Cancer. 1998: 82; 2366-2372.
29. Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast cancer incidence and survival: the Surveillance, Epidemiology and End Results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966-975.
30. Levine PH, Veneroso C. The epidemiology of inflammatory breast cancer. Semin Oncol. 2008;35:11-16.
31. EarthTrends. Economic Indicators - Tunisia. Available at: http://earthtrends.wri.org/pdf-library/country-profiles/eco-cou-788.pdf Accessed on March 15, 2009.
32. Veneroso C, Siegel R, Levine PH. Early age at first childbirth associated with advanced tumor grade in breast cancer. Cancer Detect Prev. 2008;32:215-223.